Overview
Emmanuelle Charpentier is a crispr-cas9 specialist with an H-index of 160 at Max Planck Unit (Faculty). Has been published in Science, Nature, Nature Reviews Microbiology. Based in Germany.
Biography
Emmanuelle Marie Charpentier is a French professor and researcher in microbiology, genetics, and biochemistry. She has served as a director at the Max Planck Institute for Infection Biology in Berlin since 2015. Three years later, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing". This was the first science Nobel Prize ever won by two women only.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
ScienceNat Rev MicrobiolFEMS Microbiol Lett
Key Publications
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Genome editing. The new frontier of genome engineering with CRISPR-Cas9.
Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.
Spotlight on… Emmanuelle Charpentier.
Evolution and classification of the CRISPR-Cas systems.
Areas of Expertise
Medical Specialties
Media Archive